Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Zu-Ye Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Heal…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Infective Agents, Staphylococcal Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong National Science Foundation, National Key R & D Program of China.
Abstract (Originalsprache)
Background
MDR Staphylococcus aureus infections, along with the severity of biofilm-associated infections, continue to threaten human health to a great extent. It necessitates the urgent development of novel antimicrobial and antibiofilm agents.
Objectives
To reveal the mechanism and target of cinacalcet as an antibacterial and antimicrobial agent for S. aureus.
Methods
Screening of non-antibiotic drugs for antibacterial and antibiofilm properties was conducted using a small-molecule drug library. In vivo efficacy was assessed through animal models, and the antibacterial mechanism was studied using quantitative proteomics, biochemical assays, LiP-SMap, BLI detection and gene knockout techniques.
Results
Cinacalcet, an FDA-approved drug, demonstrated antibacterial and antibiofilm activity against S. aureus, with less observed development of bacterial resistance. Importantly, cinacalcet significantly improved survival in a pneumonia model and bacterial clearance in a biofilm infection model. Moreover, the antibacterial mechanism of cinacalcet mainly involves the destruction of membrane-targeted structures, alteration of energy metabolism, and production of reactive oxygen species (ROS). Cinacalcet was found to target IcaR, inhibiting biofilm formation through the negative regulation of IcaADBC.
Conclusions
The findings suggest that cinacalcet has potential for repurposing as a therapeutic agent for MDR S. aureus infections and associated biofilms, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan Universi…
Förderung
- National Natural Science Foundation of China
- Guangdong National Science Foundation
- National Key R & D Program of China
- International Atomic Energy Agency Coordinated Research Project
Zitieren
APA
Fang, Z. Y., Zhang, Z. Y., Zheng, Y. D., Lei, D., Zhuang, J., Li, N., He, Q. Y., & Sun, X. (2024). Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae051
Vancouver
Fang ZY, Zhang ZY, Zheng YD, Lei D, Zhuang J, Li N, et al. Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae051
BibTeX
@article{Fang2024,
author = {Fang, Zu-Ye and Zhang, Zi-Yuan and Zheng, Yun-Dan and Lei, Dan and Zhuang, Jianpeng and Li, Nan and He, Qing-Yu and Sun, Xuesong},
title = {Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae051}
}
EUVIMED